EXHIBIT 10.1 PORTIONS OF THIS EXHIBIT HAVE BEEN REDACTED AND ARE THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL DOCUMENT DISTRIBUTION AGREEMENT This Agreement...Distribution Agreement • August 13th, 2003 • Osi Pharmaceuticals Inc • In vitro & in vivo diagnostic substances
EXHIBIT 10.3 Portions of this Exhibit have been redacted and are the subject of a confidential treatment request filed with the Secretary of the Securities and Exchange Commission. DISTRIBUTION AGREEMENT AMENDMENT NO. 2 This is the second amendment to...Distribution Agreement • August 13th, 2003 • Osi Pharmaceuticals Inc • In vitro & in vivo diagnostic substances
EXHIBIT 10.4 DISTRIBUTION AGREEMENT AMENDMENT NO. 3 This is an amendment to the Distribution Agreement ("Distribution Agreement") made and entered into on January 22, 2002 between: SINCLAIR PHARMACEUTICALS LTD., a corporation duly organized and...Distribution Agreement • August 13th, 2003 • Osi Pharmaceuticals Inc • In vitro & in vivo diagnostic substances
EXHIBIT 10.2 DISTRIBUTION AGREEMENT AMENDMENT NO. 1 This is an amendment to the Distribution Agreement ("Distribution Agreement") made and entered into on January 22, 2002 between: SINCLAIR PHARMACEUTICALS LTD., a corporation duly organized and...Distribution Agreement • August 13th, 2003 • Osi Pharmaceuticals Inc • In vitro & in vivo diagnostic substances
